• Home
  • BRAFV600E-Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling.

BRAFV600E-Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling.

Author List
Dacheux MA, Wu MJ, Scherzer MT, Nillson M, Murphy B, Schuman S, Ju Z, Bivona T, Lito P, Gumbleton M, Puri S, Akerley W, Wang J, Wang K, Heymach J, Kinsey CG, Negrao M, McMahon M, Vaishnavi A
Publication
bioRxiv : the preprint server for biology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/679825051
Publication Year
2025
PubMed ID
40654950
Publication Title
Dacheux MA, Wu MJ, Scherzer MT, Nillson M, Murphy B, Schuman S, Ju Z, Bivona T, Lito P, Gumbleton M, Puri S, Akerley W, Wang J, Wang K, Heymach J, Kinsey CG, Negrao M, McMahon M, Vaishnavi A. BRAFV600E-Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling. bioRxiv. 2025 May 09.
Publication Medline TA
bioRxiv
Date
2025-05-09